Molecular Evaluation of RNA-Based Immune Checkpoint Profiling in Clear Cell Renal Cell Carcinoma
Journal of Clinical Medicine · 02.06.2026 · 15 (11) · 4311
DOI: 10.3390/jcm15114311 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 02.06.2026. Verfasst von Erica Giacobbi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Medicine, Torvergata Oncoscience Research (TOR), University of Rome Tor Vergata, 00133 Rome, Italy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union NextGenerationEU.
Abstract (Originalsprache)
Background
Clear cell renal cell carcinoma is considered an immunologically “hot” tumor, with an abundance of tumor-infiltrating immune cells. This feature has a strong effect on therapeutic outcomes, especially in immune therapies. Within this context, immune checkpoint expression plays a central role in RCC immunotherapy, establishing new standards of care for patients with advanced RCC. However, most patients do not derive the maximum benefit from immune checkpoint inhibitors and may experience severe adverse effects. This may highlight the need to better understand the complexity of immunosuppressive mechanisms within the tumor microenvironment, which involves a variety of molecules. As such, this study aims to characterize the immune checkpoint status by investigating the co-expression (RNASeq) of the main checkpoints in a cohort of 16 ccRCC.
Results
In the investigated cohort, the evaluation of immune checkpoint molecules revealed the complexity of immune regulatory mechanisms within the tumor microenvironment. The marked heterogeneity in the expression of eight major immune checkpoint actors, namely, PD1, PDL1, CTLA4, PDL2, VISTA, TIM3, TIGIT, and LAG3, is matched by multiple co-expressed immune checkpoint molecules, making the immune checkpoint burden score. Specifically, immune-cold tumors displayed the highest degree of co-expression, together with high levels of PDL2 and VISTA. Furthermore, the expression of immune checkpoints, both individually and collectively, was positively associated with intratumoral immune cytolytic activity, highlighting the coexistence of immune activation and immune suppression as tightly interconnected processes.
Conclusions
The data presented here supports the concept that a ccRCC microenvironment may be driven by multiple modulatory mechanisms that allow immune escape to happen. Revealing the coordination of immune checkpoint molecules and the compensatory upregulation mechanisms may support future studies exploring multi-target immunotherapeutic strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Experimental Medicine, Torvergata Oncoscience Research (TOR), University of Rome Tor Vergata, 00133 Rome, Italy.
- Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
- Urology Unit, Department of Surgery, University of Rome Tor Vergata, 00133 Rome, Italy.
ORCID-Profile: Valeria Palumbo, Marco Carilli, Matteo Vittori, Valerio Iacovelli, Pierluigi Bove, Alessandro Mauriello, Manuel Scimeca
Förderung
- European Union NextGenerationEU
Zitieren
APA
Giacobbi, E., Palumbo, V., Servadei, F., Bonfiglio, R., Moscato, G. M. F., Carilli, M., Vittori, M., Iacovelli, V., Bove, P., Mauriello, A., & Scimeca, M. (2026). Molecular Evaluation of RNA-Based Immune Checkpoint Profiling in Clear Cell Renal Cell Carcinoma. Journal of Clinical Medicine, 15(11), 4311. https://doi.org/10.3390/jcm15114311
Vancouver
Giacobbi E, Palumbo V, Servadei F, Bonfiglio R, Moscato GMF, Carilli M, et al. Molecular Evaluation of RNA-Based Immune Checkpoint Profiling in Clear Cell Renal Cell Carcinoma. Journal of Clinical Medicine. 2026;15(11):4311. doi:10.3390/jcm15114311
BibTeX
@article{Giacobbi2026,
author = {Giacobbi, Erica and Palumbo, Valeria and Servadei, Francesca and Bonfiglio, Rita and Moscato, Giusella Maria Francesca and Carilli, Marco and Vittori, Matteo and Iacovelli, Valerio and Bove, Pierluigi and Mauriello, Alessandro and Scimeca, Manuel},
title = {Molecular Evaluation of RNA-Based Immune Checkpoint Profiling in Clear Cell Renal Cell Carcinoma},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {11},
pages = {4311},
doi = {10.3390/jcm15114311}
}
EUVIMED